These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6348341)

  • 61. [Basic and clinical examinations of 6059-S in pediatrics (author's transl)].
    Yamashita N; Sunakawa K; Hara N; Nanri S; Morikawa Y; Akita H; Hotta M; Tojo M; Ichihashi Y; Hirose M
    Jpn J Antibiot; 1981 Apr; 34(4):576-86. PubMed ID: 6457166
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Resistance of respiratory and enteral bacteria to antibiotics].
    Solórzano-Santos F; Miranda-Novales MG
    Salud Publica Mex; 1998; 40(6):510-6. PubMed ID: 9927887
    [No Abstract]   [Full Text] [Related]  

  • 63. Management of osteoarticular infections caused by Staphylococcus aureus is similar to that of other etiologies: analysis of 199 staphylococcal bone and joint infections.
    Pääkkönen M; Kallio PE; Kallio MJ; Peltola H
    Pediatr Infect Dis J; 2012 May; 31(5):436-8. PubMed ID: 22189524
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Antibiotic resistance of S. pneumoniae and H. influenzae strains isolated from patients with community acquired respiratory tract infections. BACTRO multicenter, multidisciplinary study].
    Tudose C; Bumbăcea D; Bogdan M;
    Pneumologia; 2011; 60(1):30-5. PubMed ID: 21548198
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Moxalactam therapy for bacterial infections.
    Winston DJ; Busuttil RW; Kurtz TO; Young LS
    Arch Intern Med; 1981 Nov; 141(12):1607-12. PubMed ID: 6458253
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Antibiotic sensitivity of Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus pyogenes and Branhamella catarrhalis isolated from upper respiratory tract infections in Sweden.
    Kallings I; Bengtsson S; Christensen P; Holm SE; Lind L; Kalin M
    Scand J Infect Dis Suppl; 1983; 39():100-5. PubMed ID: 6359377
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Clinical outcomes in Mexican children with febrile acute upper respiratory tract infections: no impact of antibiotic therapy.
    Carranza-Martinez MI; Newton-Sanchez O; Franco-Paredes C; Villaseñor-Sierra A
    Int J Infect Dis; 2010 Sep; 14(9):e759-63. PubMed ID: 20554465
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Sensitivity of frequent-occurring isolates in outpatients to routinely-used antibiotics (author's transl)].
    Deguchi K
    Jpn J Antibiot; 1979 Jun; 32(6):668-74. PubMed ID: 381708
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Global surveillance of bacterial susceptibility to cefaclor: 1988-1990.
    Preston DA
    Clin Ther; 1993; 15(1):88-96. PubMed ID: 8458058
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Drug sensitivity of bacteria isolated from clinical samples (author's transl)].
    Sawatari K; Mochida C; Iori F; Hayashi A; Nasu M
    Jpn J Antibiot; 1980 Jan; 33(1):87-96. PubMed ID: 6990050
    [No Abstract]   [Full Text] [Related]  

  • 71. [Clinical studies on cefminox in the field of pediatrics].
    Haruta T; Kuroki S; Ohkura K; Kobayashi Y
    Jpn J Antibiot; 1985 Mar; 38(3):737-42. PubMed ID: 3897606
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Antimicrobial activities of cefetamet against clinically isolated strains from community acquired respiratory tract infections. Part III].
    Matsumoto Y; Ishihara R; Suzuki Y; Nishinari C; Ishii Y; Nakane Y; Endo H
    Jpn J Antibiot; 1999 Jun; 52(6):469-77. PubMed ID: 10481811
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Fundamental and clinical studies on cefminox].
    Okada T; Furukawa S
    Jpn J Antibiot; 1985 Mar; 38(3):743-50. PubMed ID: 3875739
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Multicenter surveillance of antimicrobial resistance of Streptococcus pyogenes, Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis to 14 oral antibiotics.
    Hsueh PR; Huang WK; Shyr JM; Lau YJ; Liu YC; Luh KT
    J Formos Med Assoc; 2004 Sep; 103(9):664-70. PubMed ID: 15361938
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [In vitro activity of trovafloxacin in 238 respiratory pathogens].
    Alarcón T; Domingo D; Prieto N; Sánchez S; López-Brea M
    Rev Esp Quimioter; 1998 Mar; 11(1):47-51. PubMed ID: 9795289
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Fundamental and clinical studies of CS-1170 in children (author's transl)].
    Kobayashi Y; Morikawa Y; Haruta T; Fujiwara T; Yamamoto I; Nanba I; Okuhara K; Kanaoka T; Yamagami M; Mochizuki Y; Ono Y; Teramura F; Shinomiya K
    Jpn J Antibiot; 1979 Jan; 32(1):41-59. PubMed ID: 423366
    [No Abstract]   [Full Text] [Related]  

  • 77. [Clinical evaluation of cefotetan in pediatrics].
    Yanagisawa K; Hoshina H; Ichihashi H
    Jpn J Antibiot; 1983 Jun; 36(6):1271-8. PubMed ID: 6581332
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Laboratory and clinical studies of cefmenoxime in pediatric infections].
    Miyachi Y; Nakashima T; Aso K; Nishikawa K; Ogawa A; Yafuso M; Kuno K
    Jpn J Antibiot; 1982 Oct; 35(10):2459-67. PubMed ID: 6306297
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The in vitro antibacterial activity of LY127935 (6059S), a novel 1-oxa-beta-lactam antibiotic.
    Warren CA; King BA; Shannon KP; Eykyn SJ; Phillips I
    J Antimicrob Chemother; 1980 Sep; 6(5):607-15. PubMed ID: 6447682
    [No Abstract]   [Full Text] [Related]  

  • 80. Clinical evaluation of cefotetan in the treatment of lower respiratory tract infections.
    Nolen TM; Phillips HL; Hall HJ
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():233-6. PubMed ID: 6573322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.